STAREE Trial: Atorvastatin Cuts Heart Events in Seniors but Fails to Boost Disability-Free Survival
A large Australian trial shows atorvastatin reduces major cardiovascular events by 30% in healthy adults over 70, but does not significantly improve disability-free survival.